Showing results (241-250 of 253) with videos related to
Sort By:
Pageof 26
BMC Cancer|September 12, 2018
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancerAstrid E Slagter, Edwin P M Jansen, Hanneke W M van Laarhoven, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2019
Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP StudyCharlotte I Stroes, Sandor Schokker, Aafke Creemers, et al.The New England Journal of Medicine|June 1, 2012
Preoperative chemoradiotherapy for esophageal or junctional cancerP van Hagen, M C C M Hulshof, J J B van Lanschot, et al.The British Journal of Surgery|February 22, 2024
Prognostic value of Mandard score and nodal status for recurrence patterns and survival after multimodal treatment of oesophageal adenocarcinomaSofie P G Henckens, Dajia Liu, Suzanne S Gisbertz, et al.The Lancet. Oncology|August 10, 2015
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trialJoel Shapiro, J Jan B van Lanschot, Maarten C C M Hulshof, et al.International Journal of Cancer|April 29, 2014
Plasma and dietary carotenoids and vitamins A, C and E and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and NutritionMax Leenders, Anke M Leufkens, Peter D Siersema, et al.Annals of Surgery|November 8, 2014
Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survivalA Koen Talsma, Joel Shapiro, Caspar W N Looman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2021
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS TrialBen M Eyck, J Jan B van Lanschot, Maarten C C M Hulshof, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2017
Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS TrialBo Jan Noordman, Mathilde G E Verdam, Sjoerd M Lagarde, et al.BMC Cancer|July 6, 2019
Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational studyEliza R C Hagens, Mark I van Berge Henegouwen, Johanna W van Sandick, et al.Pageof 26